Details for Patent: 8,617,580
✉ Email this page to a colleague
Which drugs does patent 8,617,580 protect, and when does it expire?
Patent 8,617,580 protects TWYNEO and is included in one NDA.
This patent has twelve patent family members in ten countries.
Summary for Patent: 8,617,580
| Title: | Compositions for topical application comprising a peroxide and retinoid |
| Abstract: | The invention relates to a composition for topical application comprising as an active ingredient a peroxide and a retinoid wherein one of said peroxide and retinoid is in the form of first microparticles comprising a solid particulate matter of the active ingredient coated by a metal oxide layer and the other of said peroxide and retinoid is present in an uncoated free form or in a coated form of the active ingredient. The invention further relates to method for treating a surface condition in a subject using said composition, a method for preparing a composition exhibiting improved stability, and a kit comprising: (a) a first composition comprising a peroxide as a first active ingredient; and (b) a second composition comprising a retinoid as a second active ingredient; at least one of said first and said second active ingredient being coated by a metal oxide layer. |
| Inventor(s): | Toledano; Ofer (Kfar-Saba, IL), Sertchook; Hanan (Gedera, IL), Loboda; Natalia (Jerusalem, IL), Bar-Simantov; Haim (Modiin, IL), Shapiro; Leora (Jerusalem, IL), Abu-Reziq; Raed (Jatt Hamesholash, IL) |
| Assignee: | Sol-Gel Technologies Ltd. (Ness Ziona, IL) |
| Application Number: | 13/495,701 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Device; |
Drugs Protected by US Patent 8,617,580
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | TWYNEO | benzoyl peroxide; tretinoin | CREAM;TOPICAL | 214902-001 | Jul 26, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,617,580
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008211553 | ⤷ Try a Trial | |||
| Brazil | PI0808163 | ⤷ Try a Trial | |||
| Canada | 2677184 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 200970724 | ⤷ Try a Trial | |||
| European Patent Office | 2109445 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
